ALKERMES | 营业利润

Operating Profit 更改 日
AbbVie USD 2.96B 233M 2024-03
Acadia Pharmaceuticals USD 15.21M 19.73M 2024-03
ALKERMES USD 43.31M 11.32M 2024-03
Amgen USD 991M 280M 2024-03
Biogen USD 570M 211.1M 2024-03
BioMarin Pharmaceutical USD 78.46M 64.24M 2024-03
Bristol-Myers Squibb USD 1.51B 340M 2024-03
Eli Lilly USD 2.74B 347.8M 2024-03
Gilead Sciences USD -191000000 1.8B 2024-03
Intra Cellular Therapies USD -20952000 13.14M 2024-03
Ionis Pharmaceuticals USD -149513000 170.19M 2024-03
J&J USD 6.27B 1.45B 2024-03
Malin Corporation EUR -2200000 800K 2023-06
Merck USD 5.76B 7.69B 2024-03
Neurocrine Biosciences USD 105.3M 35.9M 2024-03
Otsuka Holdings JPY 84.76B 147.8B 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Regeneron Pharmaceuticals USD 758.5M 214.4M 2024-03
Vertex Pharmaceuticals USD 1.22B 178.1M 2024-03



ALKERMES 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.